
- Kimberly-Clark’s adjusted EPS for the fourth quarter was $1.34, falling short of the $1.52 estimate.
- The company reported net sales of $4.93 billion, surpassing the expected $4.85 billion.
- North America net sales reached $2.72 billion.
- International Personal Care net sales were $1.38 billion.
- International Family Care & Professional net sales totaled $831 million.
- For FY 2025, EPS is expected to grow at a mid-to-high single-digit rate.
- The FY 2025 EPS forecast factors in a 320 basis point negative impact due to the divestiture of PPE and exit from the private label diaper business in the U.S.
- An additional 100 basis point negative impact is anticipated from items below operating profit, influenced by higher net interest expense, a higher effective adjusted tax rate, and fewer shares outstanding.
- FY 2025 organic sales growth is projected to exceed current market growth rates, which are about two percent.
- Reported net sales for FY 2025 are expected to be negatively impacted by approximately 300 basis points due to currency translation.
- An additional 240 basis point negative impact on FY 2025 net sales is anticipated from the PPE divestiture and private label diaper business exit in the U.S.
Kimberly Clark on Smartkarma
Analyst coverage on Kimberly Clark on Smartkarma reveals a positive outlook from Baptista Research. In their report titled “Kimberly-Clark Corporation: Strategic Growth Plan Leveraging Major Brands & New Market Initiatives! – Major Drivers,” the analysts highlight the company’s strategic progress in the face of challenges. The third quarter of 2024 saw Kimberly-Clark making strides in their Powering Care strategy, led by CEO Mike Hsu. This strategy focuses on innovation, productivity optimization, and organizational restructuring to enhance competitiveness and efficiency.
A look at Kimberly Clark Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores for Kimberly Clark, the company shows a positive long-term outlook. With high scores in Dividend and Growth factors, Kimberly Clark is positioned to provide investors with a stable income stream and potential for future expansion. The company’s products, including diapers, tissues, and surgical gowns, cater to essential needs in the health and hygiene sector, indicating a resilient business model. Although the Value and Momentum scores are more moderate, the overall outlook for Kimberly Clark appears strong, especially for investors seeking steady dividends and growth opportunities.
Kimberly-Clark Corporation, a global health and hygiene company, offers a range of consumer products like diapers, tissues, and disposable face masks. With a presence in various countries worldwide, the company focuses on providing essential products for everyday needs. The Smartkarma Smart Scores for Kimberly Clark reflect a company with solid Dividend and Growth prospects, underscoring its position as a key player in the health and hygiene sector. Despite some moderation in Value and Momentum scores, Kimberly Clark remains well-positioned for long-term success in the consumer goods industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars